Location via proxy:   [ UP ]  
[Report a bug]   [Manage cookies]                
Skip to main content

Showing 1–3 of 3 results for author: Pico, A R

Searching in archive q-bio. Search in all archives.
.
  1. arXiv:2309.08478  [pdf, other

    q-bio.MN

    Current and future directions in network biology

    Authors: Marinka Zitnik, Michelle M. Li, Aydin Wells, Kimberly Glass, Deisy Morselli Gysi, Arjun Krishnan, T. M. Murali, Predrag Radivojac, Sushmita Roy, Anaïs Baudot, Serdar Bozdag, Danny Z. Chen, Lenore Cowen, Kapil Devkota, Anthony Gitter, Sara Gosline, Pengfei Gu, Pietro H. Guzzi, Heng Huang, Meng Jiang, Ziynet Nesibe Kesimoglu, Mehmet Koyuturk, Jian Ma, Alexander R. Pico, Nataša Pržulj , et al. (12 additional authors not shown)

    Abstract: Network biology is an interdisciplinary field bridging computational and biological sciences that has proved pivotal in advancing the understanding of cellular functions and diseases across biological systems and scales. Although the field has been around for two decades, it remains nascent. It has witnessed rapid evolution, accompanied by emerging challenges. These challenges stem from various fa… ▽ More

    Submitted 11 June, 2024; v1 submitted 15 September, 2023; originally announced September 2023.

    Comments: 52 pages, 6 figures, 1 table

  2. arXiv:2305.15453  [pdf

    q-bio.QM

    Drugst.One -- A plug-and-play solution for online systems medicine and network-based drug repurposing

    Authors: Andreas Maier, Michael Hartung, Mark Abovsky, Klaudia Adamowicz, Gary D. Bader, Sylvie Baier, David B. Blumenthal, Jing Chen, Maria L. Elkjaer, Carlos Garcia-Hernandez, Mohamed Helmy, Markus Hoffmann, Igor Jurisica, Max Kotlyar, Olga Lazareva, Hagai Levi, Markus List, Sebastian Lobentanzer, Joseph Loscalzo, Noel Malod-Dognin, Quirin Manz, Julian Matschinske, Miles Mee, Mhaned Oubounyt, Alexander R. Pico , et al. (14 additional authors not shown)

    Abstract: In recent decades, the development of new drugs has become increasingly expensive and inefficient, and the molecular mechanisms of most pharmaceuticals remain poorly understood. In response, computational systems and network medicine tools have emerged to identify potential drug repurposing candidates. However, these tools often require complex installation and lack intuitive visual network mining… ▽ More

    Submitted 4 July, 2023; v1 submitted 24 May, 2023; originally announced May 2023.

    Comments: 45 pages, 6 figures, 7 tables

  3. arXiv:2304.09344  [pdf

    cs.DB q-bio.QM

    BioThings Explorer: a query engine for a federated knowledge graph of biomedical APIs

    Authors: Jackson Callaghan, Colleen H. Xu, Jiwen Xin, Marco Alvarado Cano, Anders Riutta, Eric Zhou, Rohan Juneja, Yao Yao, Madhumita Narayan, Kristina Hanspers, Ayushi Agrawal, Alexander R. Pico, Chunlei Wu, Andrew I. Su

    Abstract: Knowledge graphs are an increasingly common data structure for representing biomedical information. These knowledge graphs can easily represent heterogeneous types of information, and many algorithms and tools exist for querying and analyzing graphs. Biomedical knowledge graphs have been used in a variety of applications, including drug repurposing, identification of drug targets, prediction of dr… ▽ More

    Submitted 18 April, 2023; originally announced April 2023.